GSK India "Women's Board" Sets Out To Close Gender Gap
Executive Summary
GlaxoSmithKline, which will be led by a woman CEO next year, is taking definitive steps to improve the gender balance at its Indian operations. A new "Women's Leadership Board" at GSK India is expected to bolster gender diversity across levels and develop a pipeline of female leaders for key senior positions.
You may also be interested in...
Glass Ceiling Cracked; Pharma Forges Path To Gender Equality By 2040?
One woman CEO is an improvement, but at this rate gender equality won't arrive before immuno-oncology goes generic.
GSK’s New CEO Designate Walmsley Fortifies Volume Growth Strategy
GSK’s new CEO will be Emma Walmsley, currently head of its Consumer Healthcare division. While some investors had wished for a company outsider with a ‘fresh pair of eyes’, GSK’s board decided to go for the best of both worlds: an insider with plenty of non-pharma experience.
How Sanofi Is ‘Playing To Win’ In India, Watch Diabetes Space
Sanofi India managing director Rodolfo Hrosz talks to Scrip about the company’s refreshed India strategy including in the competitive diabetes segment, which is expected to see a flurry of new product activity. While Soliqua has hit the market, all eyes are also on Novo Nordisk’s Awiqli and Cipla’s partnered inhaled insulin in the wings.